sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Significant Stake in Mural Oncology
On June 5, 2025, The Vanguard Group, Inc. released a Form 8.3 announcement regarding its stake in Mural Oncology plc. As a participant under Rule 8.3 of the Irish Takeover Panel Act, The Vanguard Group has revealed its interests in Mural Oncology’s securities.
The disclosed holdings consist of 772,883 ordinary shares, which represent a 4.48% interest in Mural Oncology. On June 4, 2025, the firm also executed a minor sale of 16 shares at a price of 2.59 USD per share.
The disclosure confirms no involvement in derivatives or agreements influencing Mural Oncology's securities, and there are no indemnity or option arrangements. The announcement follows standard protocols for transparency during the takeover process.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.